UNSPSC 51373322: Aspirin/caffeine/dihydrocodeine/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373322 Aspirin/caffeine/dihydrocodeine/promethazine is a Commodity code showing minimal alignment with recent state and local procurement activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB60459723LAS — solicits naloxone and safe drug deactivation systems, products unrelated to the pharmaceutical combination named in the code. The mismatch suggests either a classification error in the county's tagging or a deviation in how this code is applied in practice.

Seminole County issued the IFB on June 30, 2026, with a response deadline of July 26, 2023 (an apparent data inconsistency in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, meet E-Verify and drug-free workplace requirements, carry workers' compensation and commercial general liability coverage, and accept a three-month probationary period with termination-at-will provisions. The contract runs for two years with an optional one-year renewal and is potentially FEMA-funded, introducing federal compliance obligations. No other recent state or local opportunities appear under this code, and the single record does not reflect typical procurement of the pharmaceutical products the code nominally describes.